CN104689290A - Traditional Chinese medicine composition for treating epigastric fullness - Google Patents
Traditional Chinese medicine composition for treating epigastric fullness Download PDFInfo
- Publication number
- CN104689290A CN104689290A CN201510151225.1A CN201510151225A CN104689290A CN 104689290 A CN104689290 A CN 104689290A CN 201510151225 A CN201510151225 A CN 201510151225A CN 104689290 A CN104689290 A CN 104689290A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines, and relates to a traditional Chinese medicine composition for treating epigastric fullness. The traditional Chinese medicine composition is obtained through dialectic analysis of symptoms based on traditional Chinese medicine theories. The traditional Chinese medicine composition comprises, by weight, 10-20 parts of atractylodes macrocephala koidz, 3-9 parts of radix glycyrrhizae, 10-20 parts of monkshood, 9-15 parts of radix scutellariae, 9-15 parts of coptidis rhizoma, 9-15 parts of pilose asiabell roots, 9-15 parts of dried ginger, 10-20 parts of rhubarb, 9-15 parts of cape jasmine, 9-15 parts of dendrobe, 10-20 parts of fructus aurantii, 10-20 parts of jujube, 10-20 parts of blighted wheat, 10-20 parts of herba artemisiae scopariae, 9-15 parts of cortex phellodendri, 10-20 parts ofcortex magnoliae officinalis, 10-20 parts of poria cocos and 10-20 parts of sodium sulfate. The traditional Chinese medicine composition reasonably combines routine medicines, the dosage is considered, and a satisfying treatment effect can be achieved.
Description
Technical field
The invention belongs to technical field of Chinese medicines, specifically refer to a kind of Chinese medicine composition for the treatment of epigastric oppression.
Background technology
Epigastric oppression, namely gastral cavilty is full vexed, the softness of pressing not disease bitterly.Point out in " Treatise on Febrile Diseases distinguishes that sun abnormal pulse is demonstrate,proved and controls ", epigastric oppression is many not to be separated because of typhoid fever pathogenic factor in the exterior, misuse purgation, or internal injury insufficiency of primordial QI, phlegm-damp is hot and suffocating pent up caused by.This disease and lunar disease have similarity, as abdominal distention, let out the diseases such as profit, vomiting, anorexia, if but treat with lunar main formula cling conditions and be difficult to obtain curative effect, also had concurrently the disease of heat in the upper and cold in the lower outward by the burnt damp-heat accumulation of epigastric oppression a good appetite suddenly appearing in a serious disease.
Summary of the invention
The object of the invention is based on theory of Chinese medical science, by the dialectical Analyses of disease and then provide a kind of Chinese medicine composition for the treatment of this disease.
For realizing above-mentioned technical purpose, doing the technical scheme that invention adopts is: a kind of Chinese medicine composition for the treatment of epigastric oppression, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to make: Rhizoma Atractylodis Macrocephalae 10-20, Radix Glycyrrhizae 3-9, Radix Aconiti Lateralis Preparata 10-20, Radix Scutellariae 9-15, Rhizoma Coptidis 9-15, Radix Codonopsis 9-15, Rhizoma Zingiberis 9-15, Radix Et Rhizoma Rhei 10-20, Fructus Gardeniae 9-15, Herba Dendrobii 9-15, Fructus Aurantii 10-20, Fructus Jujubae 10-20, Fructus Tritici Levis 10-20, Herba Artemisiae Scopariae 10-20, Cortex Phellodendri 9-15, Cortex Magnoliae Officinalis 10-20, Poria 10-20, Natrii Sulfas 10-20.
The optimum weight proportioning of above-mentioned raw materials medicine is: the Rhizoma Atractylodis Macrocephalae 15, Radix Glycyrrhizae 6, Radix Aconiti Lateralis Preparata 15, Radix Scutellariae 12, Rhizoma Coptidis 12, Radix Codonopsis 12, Rhizoma Zingiberis 12, Radix Et Rhizoma Rhei 15, Fructus Gardeniae 12, Herba Dendrobii 12, Fructus Aurantii 15, Fructus Jujubae 15, Fructus Tritici Levis 15, Herba Artemisiae Scopariae 15, Cortex Phellodendri 12, Cortex Magnoliae Officinalis 15, Poria 15, Natrii Sulfas 15.
The instructions of taking of Chinese medicine composition provided by the present invention is: adopt the method for conventional fried Chinese medicine to get its medicine juice 300-500ml by after the mixing of the material medicine of above-mentioned weight proportion, every day takes for twice sooner or later, and every day one is secondary.
Prescription analysis: epigastric oppression morbidity by being due to human feeling's wind and cold, coldly hinder nutrient blood and cause to defend and close, the method open hole key that now emergency is dispersed drives cold-evil, and misapply purgation, cause cold-evil to enter dirty, injure middle gas, middle Jiao's lifting dereliction of duty, negative and positive phase cell, heat in the upper and cold in the lower, upward gush of turbid YIN, then epigastric oppression plug, clear sun sink, and stool lets out profit.If now still have table disease, namely interior-heat exogenous cold shape should still first by the method for dispersing to drive the method that then exopathogen imposes treating QI stagnancy by purgation, if without table disease exist; need directly to impose the side for the treatment of QI stagnancy by purgation.In Chinese medicine composition provided by the present invention, get the Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae Officinalis, Poria, Natrii Sulfas rush down wet diuretic, soil in cultivation, get Radix Et Rhizoma Rhei, Rhizoma Zingiberis, Fructus Aurantii, Natrii Sulfas, Fructus Anisi Stellati cleanse stagnant, warming middle-JIAO and regulate the flow of vital energy, Radix Glycyrrhizae, Radix Codonopsis, Fructus Jujubae invigorating middle warmer, said medicine is share, and damp-heat in middle-JIAO goes to the greatest extent, and the duty of lifting must be answered; Get the heat of Radix Scutellariae, Rhizoma Coptidis, Cortex Phellodendri, Fructus Gardeniae, Fructus Tritici Levis its part of the body cavity above the diaphragm housing the heart and lungs clear, with Herba Artemisiae Scopariae, Herba Dendrobii clearing gallbladder heat drop heart-fire, cold with the Radix Aconiti Lateralis Preparata temperature part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels.Above-mentioned all medicines share, and cooling upper-JIAO and warming lower-JIAO, middle burnt rehabilitation, then epigastric oppression is explained by oneself.Although this Chinese medicine composition is common drug on choice of drug thus, by disease dialectical Analyses accurately, conventional medicine is carried out reasonable compatibility, consideration consumption, it can obtain gratifying therapeutic effect.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
Embodiment 1
A kind of Chinese medicine composition for the treatment of epigastric oppression, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to make: Rhizoma Atractylodis Macrocephalae 15g, Radix Glycyrrhizae 6g, Radix Aconiti Lateralis Preparata 15g, Radix Scutellariae 12g, Rhizoma Coptidis 12g, Radix Codonopsis 12g, Rhizoma Zingiberis 12g, Radix Et Rhizoma Rhei 15g, Fructus Gardeniae 12g, Herba Dendrobii 12g, Fructus Aurantii 15g, Fructus Jujubae 15g, Fructus Tritici Levis 30g, Herba Artemisiae Scopariae 15g, Cortex Phellodendri 12g, Cortex Magnoliae Officinalis 15g, Poria 15g, Natrii Sulfas 15g.
In the present embodiment, adopt the material medicine of above-mentioned weight proportion to carry out clinical trial, test as follows:
Since 2013, accepted epigastric oppression patient 32 example for medical treatment, its Symptoms is: abdominal distention, and under You Yixin, appetite position vexed hardening of satisfying is main, or involves two association, and let out profit, every day 4-6 time, anorexia, notably namely diet is told, position, chest interior-heat, dry mouth, throat discomfort.Wherein 12 routine patients have the diseases caused by exogenous pathogenic factor symptoms such as heating, aversion to cold, headache concurrently.Remedy measures: first impose guizhi decoction to the patient with diseases caused by exogenous pathogenic factor symptom or Ephedrae Decoction treats, takes the Chinese medicine composition that the present embodiment provides again after diseases caused by exogenous pathogenic factor transference cure; The Chinese medicine composition taken this embodiment and provide directly is adopted to treat all the other 20 examples without patients of diseases caused by exogenous pathogenic factor symptom.
Treatment standard
1, stomach vexed sense of satisfying alleviates, and lets out sharp number of times and reduces, and can take food as effectively.
2, without diseases caused by exogenous pathogenic factor symptom, full vexed sense disappears, and lets out profit and stops, and feeding activities recovers normal for curing.
Effect is as follows:
In 20 patients of example without diseases caused by exogenous pathogenic factor symptom, take Chinese medicine composition that this embodiment provides after 1 day, having 16 routine patient's stomach to satisfy, vexed sense is both conscious alleviates, and epigastric oppression symptom is alleviated to some extent, continue to take 3-4 days, have 18 routine patients vexed sense of satisfying to disappear, feed recovers normal, and epigastric oppression is cured, though remain two routine patients symptomatic to alleviate to some extent, but still there is full vexed sense, analyze itself or by healthy energy excessively void cause curative effect excessively slow, in material medicine, add suitable invigorating middle warmer medicine continual cure.Have in the patient of diseases caused by exogenous pathogenic factor symptom in 12 examples, first take guizhi decoction or Ephedrae Decoction 1-3 days, after its diseases caused by exogenous pathogenic factor transference cure, have 3 routine patient's epigastric oppression symptoms to disappear thereupon, remain 9 routine patients take Chinese medicine composition 2-4 days that this embodiment provides after epigastric oppression symptom all disappear, get well.Known by above-mentioned test, this Chinese medicine composition has significant curative effect on treatment epigastric oppression one disease.
Embodiment 2
A kind of Chinese medicine composition for the treatment of epigastric oppression, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to make: Rhizoma Atractylodis Macrocephalae 12g, Radix Glycyrrhizae 9g, Radix Aconiti Lateralis Preparata 12g, Radix Scutellariae 12g, Rhizoma Coptidis 9g, Radix Codonopsis 12g, Rhizoma Zingiberis 9g, Radix Et Rhizoma Rhei 18g, Fructus Gardeniae 9g, Herba Dendrobii 12g, Fructus Aurantii 12g, Fructus Jujubae 18g, Fructus Tritici Levis 12g, Herba Artemisiae Scopariae 18g, Cortex Phellodendri 9g, Cortex Magnoliae Officinalis 18g, Poria 12g, Natrii Sulfas 18g.
Model case
Man, 21 years old, time medical, the full anorexia of stomach, obtain food and namely tell, hands hardened by appetite, frequent micturition, and defecate rare, shapeless, every day defecates 5-6 time, has the diseases caused by exogenous pathogenic factor symptoms such as headache, heating, aversion to cold concurrently, body temperature 38.2 DEG C simultaneously.Inquiring its thing of taking medicine, is owing to wrongly taking caused by Baihu Tang.
Analyze this patient show symptom, be because it is young and aggressive, healthy energy is sufficient, therefore shows sun completely not sagging, first should adopt the medicine dispersed its pathogenic factor in the exterior clear when its diseases caused by exogenous pathogenic factor symptom is still deposited, and advises that it is first taken Ephedrae Decoction and observes after its diseases caused by exogenous pathogenic factor symptom is gone for 1st.Take Ephedrae Decoction after one day, diseases caused by exogenous pathogenic factor symptom loses but epigastric oppression symptom is still deposited, and then takes the Chinese medicine composition provided in this embodiment, and after taking 2, epigastric oppression symptom disappears completely, and diet, body temperature, all recoveries movable are normally.
Embodiment 3
A kind of Chinese medicine composition for the treatment of epigastric oppression, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to make: Rhizoma Atractylodis Macrocephalae 18g, Radix Glycyrrhizae 3g, Radix Aconiti Lateralis Preparata 18g, Radix Scutellariae 9g, Rhizoma Coptidis 12g, Radix Codonopsis 9g, Rhizoma Zingiberis 15g, Radix Et Rhizoma Rhei 12g, Fructus Gardeniae 15g, Herba Dendrobii 9g, Fructus Aurantii 18g, Fructus Jujubae 12g, Fructus Tritici Levis 18g, Herba Artemisiae Scopariae 12g, Cortex Phellodendri 15g, Cortex Magnoliae Officinalis 12g, Poria 18g, Natrii Sulfas 12g.
Model case
Female, 45 years old, time medical, the pit of the stomach was irritated, and appetite is satisfied vexed, and throat has expectorant to tell, frequent micturition, anorexia, and epigastric oppression symptom is obvious, but without diseases caused by exogenous pathogenic factor symptoms such as heating, headache, aversion to cold.
Take Chinese medicine composition that the present embodiment provides after 2 days, stomach is soft, and full vexed sense disappears, and diet recovers normally, and epigastric oppression is cured.
Embodiment 4
A kind of Chinese medicine composition for the treatment of epigastric oppression, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to make: the Rhizoma Atractylodis Macrocephalae 10 parts, 9 parts, Radix Glycyrrhizae, Radix Aconiti Lateralis Preparata 10 parts, Radix Scutellariae 15 parts, Rhizoma Coptidis 9 parts, Radix Codonopsis 15 parts, Rhizoma Zingiberis 9 parts, Radix Et Rhizoma Rhei 20 parts, Fructus Gardeniae 9 parts, Herba Dendrobii 15 parts, Fructus Aurantii 10 parts, 20 parts, Fructus Jujubae, Fructus Tritici Levis 10 parts, Herba Artemisiae Scopariae 20 parts, Cortex Phellodendri 9 parts, Cortex Magnoliae Officinalis 20 parts, 10 parts, Poria, 20 parts, Natrii Sulfas.
Embodiment 5
A kind of Chinese medicine composition for the treatment of epigastric oppression, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to make: the Rhizoma Atractylodis Macrocephalae 20 parts, 3 parts, Radix Glycyrrhizae, Radix Aconiti Lateralis Preparata 20 parts, Radix Scutellariae 9 parts, Rhizoma Coptidis 15 parts, Radix Codonopsis 9 parts, Rhizoma Zingiberis 15 parts, Radix Et Rhizoma Rhei 10 parts, Fructus Gardeniae 15 parts, Herba Dendrobii 9 parts, Fructus Aurantii 20 parts, 10 parts, Fructus Jujubae, Fructus Tritici Levis 20 parts, Herba Artemisiae Scopariae 10 parts, Cortex Phellodendri 15 parts, Cortex Magnoliae Officinalis 10 parts, 20 parts, Poria, 10 parts, Natrii Sulfas.
Claims (2)
1. treat the Chinese medicine composition of epigastric oppression for one kind, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to make: Rhizoma Atractylodis Macrocephalae 10-20, Radix Glycyrrhizae 3-9, Radix Aconiti Lateralis Preparata 10-20, Radix Scutellariae 9-15, Rhizoma Coptidis 9-15, Radix Codonopsis 9-15, Rhizoma Zingiberis 9-15, Radix Et Rhizoma Rhei 10-20, Fructus Gardeniae 9-15, Herba Dendrobii 9-15, Fructus Aurantii 10-20, Fructus Jujubae 10-20, Fructus Tritici Levis 10-20, Herba Artemisiae Scopariae 10-20, Cortex Phellodendri 9-15, Cortex Magnoliae Officinalis 10-20, Poria 10-20, Natrii Sulfas 10-20.
2. a kind of Chinese medicine composition for the treatment of epigastric oppression according to claim 1, it is characterized in that, the optimum weight proportioning of described material medicine is: the Rhizoma Atractylodis Macrocephalae 15, Radix Glycyrrhizae 6, Radix Aconiti Lateralis Preparata 15, Radix Scutellariae 12, Rhizoma Coptidis 12, Radix Codonopsis 12, Rhizoma Zingiberis 12, Radix Et Rhizoma Rhei 15, Fructus Gardeniae 12, Herba Dendrobii 12, Fructus Aurantii 15, Fructus Jujubae 15, Fructus Tritici Levis 15, Herba Artemisiae Scopariae 15, Cortex Phellodendri 12, Cortex Magnoliae Officinalis 15, Poria 15, Natrii Sulfas 15.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510151225.1A CN104689290B (en) | 2015-04-02 | 2015-04-02 | A kind of Chinese medicine composition for treating epigastric fullness |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510151225.1A CN104689290B (en) | 2015-04-02 | 2015-04-02 | A kind of Chinese medicine composition for treating epigastric fullness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104689290A true CN104689290A (en) | 2015-06-10 |
| CN104689290B CN104689290B (en) | 2018-04-27 |
Family
ID=53337114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510151225.1A Expired - Fee Related CN104689290B (en) | 2015-04-02 | 2015-04-02 | A kind of Chinese medicine composition for treating epigastric fullness |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104689290B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102772759A (en) * | 2012-07-05 | 2012-11-14 | 李承平 | Group of tablets for clearing heat, eliminating mass and removing stasis |
-
2015
- 2015-04-02 CN CN201510151225.1A patent/CN104689290B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102772759A (en) * | 2012-07-05 | 2012-11-14 | 李承平 | Group of tablets for clearing heat, eliminating mass and removing stasis |
Non-Patent Citations (4)
| Title |
|---|
| 孙世发: "《中华医方·内科篇·脾系病》", 31 March 2015 * |
| 朱延胜等: "半夏泻心汤加减治疗心下痞36例体会", 《甘肃中医学院学报》 * |
| 李宇航: "半夏泻心汤治疗心下痞证治规律的研究", 《北京中医杂志》 * |
| 谢炜等: "《陈宝田教授经方临床应用》", 30 April 2014 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104689290B (en) | 2018-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101766802B (en) | Chinese medicine composite for treatment of acute gastroenteritis and preparation method thereof | |
| CN102895603B (en) | Chinese herbal medicine for treating gastro-intestinal diseases | |
| CN103316174B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis and preparation method thereof | |
| CN1840144A (en) | Medicine for treating gastric disease | |
| CN100998722B (en) | Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia | |
| CN104740437A (en) | Traditional Chinese medicine composition for treating constipation and preparation method of traditional Chinese medicine composition | |
| CN103301438B (en) | Traditional Chinese medicine composition for treating gastroptosis and preparation method thereof | |
| CN104906333A (en) | Traditional Chinese medicine composition for enhancing cardio-pulmonary function | |
| CN102614471B (en) | Traditional Chinese medicine for treating breast carcinoma | |
| CN102274466B (en) | Chinese medicinal composition for treating gastritis | |
| CN100998825A (en) | Oral Chinese medicine for treating yin blood insufficiency type virus myocarditis | |
| CN103251864A (en) | Chinese medicament for treating pneumonia and preparation method thereof | |
| CN100998682A (en) | Oral traditional Chinese medicine for treating serious hyposomnia of qi-blood disharmony type | |
| CN103127351B (en) | Traditional Chinese medicine for treating premature menstruation | |
| CN102940716A (en) | Traditional Chinese medicine for treatment of uterine prolapse | |
| CN104689290A (en) | Traditional Chinese medicine composition for treating epigastric fullness | |
| CN103690870A (en) | Traditional Chinese medicine for treating dampness-heat internal stasis and preparation method of traditional Chinese medicine | |
| CN104667249A (en) | Traditional Chinese medicine composition for treating primary dysmenorrhea | |
| CN100998728A (en) | Oral traditional Chinese medicine for treating astriction of insufficiency of yang type | |
| CN104398740A (en) | Traditional Chinese medicinal composition for treating difficult urination | |
| CN103933269A (en) | Traditional Chinese medicine for treating metrorrhagia disease | |
| CN103816436A (en) | Traditional Chinese medicine composition for treating downward flow of damp-heat | |
| CN102716244A (en) | Vietnamese sophora root Chinese medicine preparation for treating headache and preparation method of same | |
| CN102058863B (en) | Chinese medicinal composition for eliminating body edema | |
| CN100998749A (en) | Oral traditional Chinese medicine for treating astriction of intestine-heat type |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information |
Inventor after: Wang Caiyun Inventor after: Wan Long Inventor before: Wang Ailing Inventor before: Gao Xiaoming |
|
| CB03 | Change of inventor or designer information | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20180326 Address after: 266200 Xinxing Road, Jimo District, Qingdao, Shandong Province, No. 78 Applicant after: Wang Caiyun Address before: The sea road in Rongcheng city of Weihai city of Shandong Province, No. 116 264300 Applicant before: Wang Ailing |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180427 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |